本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ensysce Biosciences Inc.

0.5559
+0.02895.48%
盘后:0.5500-0.0059-1.06%19:57 EDT
成交量:131.62万
成交额:70.37万
市值:1,081.60万
市盈率:-0.20
高:0.5646
开:0.5100
低:0.4854
收:0.5270
52周最高:2.75
52周最低:0.2300
股本:1,945.68万
流通股本:1,837.90万
量比:1.25
换手率:7.16%
股息:- -
股息率:- -
每股收益(TTM):-2.7523
每股收益(LYR):-3.9790
净资产收益率:-1295.09%
总资产收益率:-185.51%
市净率:-13.84
市盈率(LYR):-0.14

数据加载中...

2024/03/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/15

重要事件披露

Form 8-K - Current report
2024/03/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/29

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/21

SEC问询函

Form CORRESP - Correspondence
2023/11/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/18

重要事件披露

Form 8-K - Current report
2023/11/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/24

重要事件披露

Form 8-K - Current report
2023/10/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/28

重要事件披露

Form 8-K - Current report
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]